CancerSpot Blood Test Study
3.6 Science And Tech, The Hindu, 2026-11-19
Bengaluru-based Strand Life Sciences developed CancerSpot, a blood test using DNA sequencing and AI to read DNA methylation patterns in cell-free DNA. In an independent validation cohort it detected 72% of cancer cases with a 1.4% false-positive rate. The four-year study involved 1,480 participants and 43 hospitals across India and covered 14 cancer types. Published in PNAS. Higher circulating DNA levels strengthened cancer signals, contrary to expectation.